Callan Capital LLC Buys Shares of 591 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Callan Capital LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 591 shares of the medical equipment provider’s stock, valued at approximately $236,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Baystate Wealth Management LLC boosted its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC boosted its position in shares of Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares during the period. Headinvest LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $28,000. Able Wealth Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Finally, Atticus Wealth Management LLC boosted its position in shares of Intuitive Surgical by 85.4% during the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 41 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded up $2.44 during trading on Wednesday, hitting $444.74. The company had a trading volume of 1,076,050 shares, compared to its average volume of 1,506,063. The company has a market cap of $157.75 billion, a P/E ratio of 79.84, a PEG ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $448.10. The business’s 50-day moving average is $413.05 and its 200 day moving average is $388.89.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s revenue was up 11.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.00 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 175 shares of Intuitive Surgical stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now directly owns 883 shares in the company, valued at approximately $343,628.28. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the transaction, the director now directly owns 25,319 shares in the company, valued at approximately $9,385,753.30. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 175 shares of Intuitive Surgical stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now owns 883 shares in the company, valued at $343,628.28. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,956 shares of company stock worth $6,927,011. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ISRG shares. BTIG Research boosted their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Robert W. Baird reduced their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. Evercore ISI boosted their price objective on Intuitive Surgical from $385.00 to $425.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 2nd. Citigroup boosted their target price on Intuitive Surgical from $462.00 to $512.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $410.32.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.